Medicxi

Medicxi Overview

Investor Type Venture Capital
Status Active
Professionals 12
Professionals
Investments 37
Portfolio 28
Exits 7
Exits

Medicxi General Information

Description

Founded in 2016, Medicxi is a venture capital firm headquartered in London, United Kingdom with regional offices in Geneva and Saint Helier. The firm prefers to invest in the healthcare, academia, biotech and pharmaceutical sectors.

Contact Information

Website
Formerly Known As
Index Ventures Life Sciences
Year Founded
2016
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 25 Great Pulteney Street
  • London W1F 9LT
  • England, United Kingdom
+44 020 0000 0000

Medicxi Investments (37)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Vaxcyte 26-Mar-2020 Later Stage VC 00000 Drug Discovery Clinical Trials - Phase 1
00000000 000000000 09-Jan-2020 00000 00000 000.00 Biotechnology Pre-Clinical Trials 0000è00 000000 00
000000 & 0000000 18-Sep-2019 00000 00000 000.00 Biotechnology Startup
0000000000 0000000 08-Jul-2019 00000 00000 000.00 Drug Discovery Pre-Clinical Trials 000 0000000 00.0
0000000 0000000000 15-May-2019 00000 00000 00000 Biotechnology Clinical Trials - Phase 3 000 0000000 00.0
00000000 000000000 08-Apr-2019 00000 00000 0000 Biotechnology Pre-Clinical Trials 0000è00 000000 00
0000 00000000000 02-Apr-2019 00000 00000 0000 Biotechnology Clinical Trials - Phase 1 00000000 0000000 00.0
0000000000 000 29-Mar-2019 00000 00000 000.00 Drug Discovery Stealth 0000è00 000000 00
Yukin Therapeutics 15-Mar-2019 Early Stage VC 00.000 Drug Discovery Startup
Orexia 06-Feb-2019 Early Stage VC 00.000 Pharmaceuticals Startup 000000000 00 00000000 00.0
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medicxi Exits (6)

To view Medicxi‘s complete exit history, request access >>
Company Name Exit Date Exit Type Exit Size
SuperX 06-Apr-2020 Bankruptcy: Liquidation
0000000 0000000000 25-Oct-2019 000 00000
00000000 07-Dec-2018 000 00000
000000 00000000000 12-Feb-2018 000000000000000000 000
Cosmo Pharmaceuticals 31-Mar-2017 Public Investment 2nd Offering 00000
Aravive Inc 21-Mar-2014 IPO 00000

Medicxi Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Medicxi‘s full profile, request access.

Request a free trial

Medicxi Team (22)

Name Title Deals Funds Boards Office
Francesco De Rubertis Ph.D Co-Founder & Partner 0 0 0 Geneva, Switzerland
Kevin Johnson Ph.D Co-Founder & Partner 00 0 0 London, United Kingdom
Michèle Ollier MD Co-Founder & Partner 00 0 00 Geneva, Switzerland
Moncef Slaoui Ph.D Partner & Member of Scientific Advisory Board 0 0 0 London, United Kingdom
Giovanni Mariggi Ph.D Partner 0 0 0 London, United Kingdom

5 Former Team Members